Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Israeli team grows heart cells from embryonic cells:

This article was originally published in Clinica

Executive Summary

Scientists from the Technion-Israel Institute of Technology, Haifa, say they have become the first to successfully grow the precursors of heart cells from human embryonic stem cells. Embryonic stem cells can proliferate far more than stem cells derived from adult tissues and can, therefore, produce the many million of cells needed to repair organs, say the researchers, whose findings appear in the Journal of Clinical Investigation (August).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT072405

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel